Physician profile
Robert Burnham
NPI 1174055560
$16,637.83
in general payments reported to CMS, 2019-2025
8 companies · $962 in 2025
The $962 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6.08 · 2020: $19.67 · 2021: $2,612 · 2022: $5,722 · 2023: $5,899 · 2024: $1,417 · 2025: $962.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,209 · Travel and Lodging: $2,545 · Food and Beverage: $2,524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,208.97 |
| Travel and Lodging | $2,544.96 |
| Food and Beverage | $2,523.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $6,025.73 | 2022-2024 | Trigen Intertan |
| Stryker Corporation | $5,314.73 | 2020-2024 | Mako |
| Medical Device Business Services, INC. | $2,163.57 | 2021-2025 | Velys |
| Zimmer Biomet Holdings, INC. | $1,437.01 | 2023-2025 | Persona |
| Depuy Synthes Sales INC. | $1,238.40 | 2021-2025 | Velys, Inhance, Actis |
| Microport Orthopedics INC | $413.46 | 2019-2023 | Mpo Hip System |
| Ethicon US, LLC | $25.43 | 2025 | Dermabond, Ethicon |
| Fidia Pharma USA INC. | $19.50 | 2024 | Hymovis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Burnham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.